Related Articles
Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens
Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis
Personalized peptide vaccination in patients with refractory non-small cell lung cancer
Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients